Literature DB >> 9574871

Vascular remodeling and growth factor gene expression in the rat lung during hypoxia.

M Pfeifer1, F C Blumberg, K Wolf, P Sandner, D Elsner, G A Riegger, A Kurtz.   

Abstract

Recent studies suggest that the vasoactive peptides endothelin-1 and -3 and the mitogens VEGF and PDGF-A and -B could be involved in the pathogenesis of hypoxic pulmonary hypertension. We were interested to investigate whether these peptides could also be involved in the vascular remodeling occurring during chronic hypoxia (10% oxygen; 1 and 3 weeks) in the rat. Hypoxia increased significantly systolic right ventricular pressure and typical morphological signs of vascular remodeling were found. This was accompanied by increased ET-1 and the ET-3 mRNA expression after acute (6 h; P < 0.05) and chronic hypoxia of 1 (P < 0.05) and 3 weeks (P < 0.05). In contrast, we found no effects of hypoxia on the gene expression of VEGF and PDGF-A and -B in the lung. Our findings indicate that ET-3 in addition to ET-1 could be involved in the process of hypoxia-induced vascular remodeling, whereas it appears less likely that the mitogens VEGF and PDGF-A and -B are essentially involved in the pathogenesis of hypoxic pulmonary hypertension.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9574871     DOI: 10.1016/s0034-5687(97)00102-3

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  2 in total

1.  Inhibition of phosphatidylinositol 3-kinase/Akt signaling attenuates hypoxia-induced pulmonary artery remodeling and suppresses CREB depletion in arterial smooth muscle cells.

Authors:  Chrystelle V Garat; Joseph T Crossno; Timothy M Sullivan; Jane E B Reusch; Dwight J Klemm
Journal:  J Cardiovasc Pharmacol       Date:  2013-12       Impact factor: 3.105

2.  Placenta growth factor and vascular endothelial growth factor B expression in the hypoxic lung.

Authors:  Michelle Sands; Katherine Howell; Christine M Costello; Paul McLoughlin
Journal:  Respir Res       Date:  2011-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.